Skip to main content Skip to secondary navigation

Genentech’s Business Model

Duration
3:30
Part of Series
Entrepreneurial Thought Leaders

Joe McCracken, Vice President of Business Development at Genentech, describes Genentech’s business model where commercialization takes a back seat to science. He differentiates this from other typical pharmaceutical companies and shows how this affects the culture at Genentech. He credits this approach for the successful innovation of several hugely profitable drugs.